Reimagining Tomorrow. Restoring Lives Today
At LigronBio, we are driven by a bold mission to transform the treatment of neurodegenerative diseases through the convergence of artificial intelligence, precision gene therapy, and molecular glue therapeutics. Our commitment is to develop innovative, disease-modifying therapies that target the root cause of Alzheimer's disease, Parkinson's disease, ALS, and FTD—restoring brain health and improving the lives of patients worldwide.
Accelerating Drug Discovery
Our team of data scientists and biotech experts is dedicated to accelerating the drug discovery process. By combining cutting-edge technology with a deep understanding of biology and chemistry, we can identify new drug targets and develop more effective therapies.
Versatility in Application
Our molecular glue technology have a wide range of potential applications, from cancer treatment to neurological disorders. We are constantly exploring new ways to use our technology to address unmet medical needs and improve patient outcomes.
Our Impact
Revolutionize Molecular Glue Research With LigronBio
At LigronBio, we are dedicated to pushing the boundaries of biotechnology and bringing new, life-changing treatments to clinic. If you're ready to join us on this journey, let's get started today.
2
Patents Filed
3
Industry Partners
1
University collaborations
Undisclosed amount
Investment raised